Drug · DIN 02475596
ALPHANATE
RECONSTITUTED WITH 10 ML DILUENT
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since May 11, 2018.
- Drug Identification Number (DIN)
- 02475596
- Company (DIN owner)
- Grifols Biologicals LlcLos Angeles, California, United States
- Schedule
- Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Von willebrand factor and coag. fact. viii in comb B02BD06
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANTIHEMOPHILIC FACTOR (HUMAN) | 1000 UNIT | VIAL |
| VON WILLEBRAND FACTOR (HUMAN) | 1200 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 11, 2018: NOC 20854New Drug Submission (NDS)
Other DINs named ALPHANATE
- DIN 02475561 · Approved
- DIN 02475588 · Approved
- DIN 02475618 · Approved
- DIN 02475626 · Approved